Læknaneminn - 01.04.2018, Blaðsíða 137

R
an
ns
ók
na
rv
er
ke
fn
i 3
. á
rs
n
em
a
20
17
13
7
Krabbamein í kvenlíffærum
Heimildaskrá – framhald
ac.uk/abstract/MED/2516120.
29. Lombard KA, Olson L, Nelson SE, Rebouche
CJ. Carnitine status of lactoovovegetarians
and strict vegetarian adults and children. Am J
Clin Nutr. 1989;50(2):301­306. doi:10.1079/
PNS2005481.
30. Rebouche CJ, Engel AG. Tissue distribution
of carnitine biosynthetic enzymes in
man. BBA - Gen Subj. 1980;630(1):22­29.
doi:10.1016/0304­4165(80)90133­6.
31. Celestino­Soper PBS, Shaw CA, Sanders SJ,
et al. Use of array CGH to detect exonic copy
number variants throughout the genome in
autism families detects a novel deletion in
TMLHE. Hum Mol Genet. 2011;20(22):4360­
4370. doi:10.1093/hmg/ddr363.
32. Celestino­Soper PBS, Violante S, Crawford
EL, et al. A common X­linked inborn error
of carnitine biosynthesis may be a risk factor
for nondysmorphic autism. Proc Natl Acad Sci
U S A. 2012;109(21):7974­7981. doi:10.1073/
pnas.1120210109.
33. Rashidi­Nezhad A, Talebi S, Saebnouri
H, Akrami SM, Reymond A. The effect
of homozygous deletion of the BBOX1
and Fibin genes on carnitine level and acyl
carnitine profile. BMC Med Genet. 2014;15:75.
doi:10.1186/1471­2350­15­75.
34. Vaz FM, Wanders RJA. Carnitine biosynthesis
in mammals. Biochem J. 2002;361(Pt 3):417­
429. http://www.ncbi.nlm.nih.gov/pmc/
articles/PMC1222323/.
24. Yamashita H, Okuma K, Kawana K, et al.
Comparison between conventional surgery
plus postoperative adjuvant radiotherapy and
concurrent chemoradiation for FIGO stage
IIB cervical carcinoma: a retrospective study.
American journal of clinical oncology. Dec
2010;33(6):583­586.
25. Grigsby PW, Zighelboim I, Powell
MA, Mutch DG, Schwarz JK. In vitro
chemoresponse to cisplatin and outcomes
in cervical cancer. Gynecol Oncol. Jul
2013;130(1):188­191.
26. Ansink A, Barros Lopes A, Naik R, Mo­
naghan JM. Recurrent stage IB cervical
carcinoma: evaluation of the effectiveness
of routine follow up surveillance. BJOG:
An International Journal of Obstetrics &
Gynaecology. 1996;103(11):1156­1158.
27. Duyn A, Van Eijkeren M, Kenter G,
Zwinderman K, Ansink A. Recurrent cervical
cancer: detection and prognosis. Acta obstetricia
et gynecologica Scandinavica. 2002;81(8):759­
763.
28. Ratner ES, Foran KA, Schwartz PE, Minkin
MJ. Sexuality and intimacy after gynecological
cancer. Maturitas. May 2010;66(1):23­26.
29. Andrae B, Andersson TM, Lambert PC, et al.
Screening and cervical cancer cure: population
based cohort study. BMJ (Clinical research ed.).
Mar 01 2012;344:e900.
30. Sankaranarayanan R, Ferlay J. Worldwide
burden of gynaecological cancer: the size of
the problem. Best practice & research. Clinical
obstetrics & gynaecology. Apr 2006;20(2):207­
225.
31. Krabbamein í legbol. 2012; http://
krabbameinsskra.is/?icd=C54. Sótt 10.03.15.
32. Holland C. Chapter 10: Endometrial
cancer. In: Shafi MI, Earl HM, Tan LT, eds.
Gynaecological Oncology: Cambridge University
Press; 2010.
33. Burke WM, Orr J, Leitao M, et al.
Endometrial cancer: a review and current
management strategies: part I. Gynecologic
oncology. Aug 2014;134(2):385­392.
34. Amant F, Cadron I, Fuso L, et al. Endometrial
carcinosarcomas have a different prognosis
and pattern of spread compared to high­risk
epithelial endometrial cancer. Gynecologic
oncology. Aug 2005;98(2):274­280.
35. Amant F, Moerman P, Neven P, Timmerman
D, Van Limbergen E, Vergote I. Endometrial
cancer. Lancet. Aug 6­12 2005;366(9484):491­
505.
36. Kaaks R, Lukanova A, Kurzer MS. Obesity,
endogenous hormones, and endometrial cancer
risk: a synthetic review. Cancer epidemiology,
biomarkers & prevention : a publication of
the American Association for Cancer Research,
cosponsored by the American Society of Preventive
Oncology. Dec 2002;11(12):1531­1543.
37. Cetin I, Cozzi V, Antonazzo P. Infertility as a
Cancer Risk Factor ­ A Review. Placenta. Oct
2008;29:S169­S177.
38. Fisher B, Costantino JP, Redmond CK, et al.
Endometrial Cancer in Tamoxifen­Treated
Breast­Cancer Patients ­ Findings from the
National Surgical Adjuvant Breast and Bowel
Project (Nsabp) B­14. Journal of the National
Cancer Institute. Apr 6 1994;86(7):527­537.
39. van Leeuwen FE, Benraadt J, Coebergh JW, et
al. Risk of endometrial cancer after tamoxifen
treatment of breast cancer. Lancet. Feb 19
1994;343(8895):448­452.
40. Garg K, Soslow RA. Lynch syndrome
(hereditary non­polyposis colorectal cancer)
and endometrial carcinoma. Journal of clinical
pathology. Aug 2009;62(8):679­684.
41. Marchetti M, Vasile C, Chiarelli S.
Endometrial cancer: asymptomatic
endometrial findings. Characteristics
of postmenopausal endometrial cancer.
European journal of gynaecological oncology.
2005;26(5):479­484.
42. Kerimoglu OS, Pekin A, Yilmaz SA, Bakbak
BB, Celik C. Pyometra in elderly post­
menopausal women: a sign of malignity.
European journal of gynaecological oncology.
2015;36(1):59­61.
43. Referral guidelines for suspected cancer. The
National Institute for Health and Care
Excellence;2005.
44. Saso S, Chatterjee J, Georgiou E, Ditri AM,
Smith JR, Ghaem­Maghami S. Endometrial
cancer. Bmj. 2011;343:d3954.
45. Buchanan EM, Weinstein LC, Hillson C.
Endometrial cancer. American family physician.
Nov 15 2009;80(10):1075­1080.
46. Ben­Yehuda OM, Kim YB, Leuchter RS. Does
hysteroscopy improve upon the sensitivity
of dilatation and curettage in the diagnosis
of endometrial hyperplasia or carcinoma?
Gynecologic oncology. Jan 1998;68(1):4­7.
47. Plataniotis G, Castiglione M, Group EGW.
Endometrial cancer: ESMO Clinical Practice
Guidelines for diagnosis, treatment and
follow­up. Annals of oncology : official journal
of the European Society for Medical Oncology /
ESMO. May 2010;21 Suppl 5:v41­45.
48. Clark TJ, Mann CH, Shah N, Khan KS,
Song F, Gupta JK. Accuracy of outpatient
endometrial biopsy in the diagnosis
of endometrial cancer: a systematic
quantitative review. BJOG : an international
journal of obstetrics and gynaecology. Mar
2002;109(3):313­321.
49. Amant F, Mirza MR, Creutzberg CL. Cancer
of the corpus uteri. International journal of
gynaecology and obstetrics: the official organ of
the International Federation of Gynaecology and
Obstetrics. Oct 2012;119 Suppl 2:S110­117.
50. Practice guidelines: uterine corpus­­
endometrial cancer. Society of Gynecologic
Oncologists Medical Practice Committee.
Oncology (Williston Park). Jan 1998;12(1):122­
126.
51. Fattaneh A. Tavassoli PD. Pathology and
genetics tumours of the breast and female genital
organs: IARC WHO classification of tumours.:
IARCPress; 2003.
52. Setiawan VW, Yang HP, Pike MC, et al.
Type I and II endometrial cancers: have
they different risk factors? Journal of clinical
oncology : official journal of the American Society
of Clinical Oncology. Jul 10 2013;31(20):2607­
2618.
53. Shafi MI, Earl HM, Tan LT. Gynaecological
Oncology. 2010.
54. Oncology FCoG. FIGO staging for
carcinoma of the vulva, cervix, and corpus
uteri. International journal of gynaecology and
obstetrics: the official organ of the International
Federation of Gynaecology and Obstetrics. May
2014;125(2):97­98.
55. Lethaby A, Mukhopadhyay A, Naik R.
Total versus subtotal hysterectomy for
benign gynaecological conditions. The
Cochrane database of systematic reviews.
2012;4:CD004993.
56. Guidelines version 1.2014. Uterine Neoplasms.
National Comprehensive Cancer Network.
57. Einarsson JI, Suzuki Y. Total laparoscopic
hysterectomy: 10 steps toward a successful
procedure. Reviews in obstetrics & gynecology.
Winter 2009;2(1):57­64.
58. Gemignani ML, Curtin JP, Zelmanovich
J, Patel DA, Venkatraman E, Barakat RR.
Laparoscopic­assisted vaginal hysterectomy
for endometrial cancer: clinical outcomes and
hospital charges. Gynecologic oncology. Apr
1999;73(1):5­11.
59. Verdecchia A, Francisci S, Brenner H, et al.
Recent cancer survival in Europe: a 2000­02
period analysis of EUROCARE­4 data. The
Lancet. Oncology. Sep 2007;8(9):784­796.
60. Tantravahi SK, Werner TL. Locally recurrent
endometrial cancer: a case report. Journal of
the National Comprehensive Cancer Network :
JNCCN. Apr 2012;10(4):442­445.